Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cloma Pharma Laboratories is a specialized nutraceutical company focused on the development and commercialization of high-potency dietary supplements, particularly in the weight loss and sports nutrition categories. The company is widely recognized for its ECA stack-inspired formulations, which typically combine ephedra extract, caffeine, and aspirin-like ingredients to promote thermogenesis. Its flagship product line includes well-known brands such as Methyldrene, Black Spider, and Asia Black. Cloma Pharma targets consumers seeking significant metabolic support, appetite suppression, and increased energy levels for athletic performance. The company operates primarily in the commercial stage, distributing its products globally through various retail and online channels. All products are manufactured in facilities that adhere to Good Manufacturing Practices (GMP) to ensure quality and potency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cloma Pharma.